The FDA granted regenerative medicine advanced therapy (RMAT) status to experimental cell therapy Lomecel-B for mild ...

Foralumab is an antibody being developed by Tiziana Life Sciences that's designed to block CD3, a protein on the surface of ...

What is Kisunla for Alzheimer’s? Kisunla (donanemab-azbt) is an antibody-based therapy approved in the U.S. to treat adults with early symptomatic Alzheimer’s disease. This includes people with mild ...

Eli Lilly's donanemab, now Kisunla, was approved by the U.S. Food and Drug Administration for patients with early symptomatic ...

Providing care and support for someone with a chronic health challenge comes with its own unique set of stresses. You may be juggling doctors’ appointments, timing multiple medications, and keeping on ...

We’re barely into the summer months, and temperatures across the United States are soaring. Heat is expected to intensify as we get deeper into the season, with U.S. temperatures surpassing those of ...

Note: This story was updated June 21, 2024, to correct that SNK01 was given approval by NKGen Biotech’s Safety Review Committee. SNK01, a natural killer (NK) cell therapy being developed by NKGen ...

The safety and effectiveness of oral therapy candidate buntanetap are comparable in people with early Alzheimer’s disease regardless of whether they do or do not carry a genetic risk factor known as ...